Cargando…
Structure-based discovery of two antiviral inhibitors targeting the NS3 helicase of Japanese encephalitis virus
Japanese encephalitis virus (JEV) is a flavivirus that threatens more than half of the world’s population. Vaccination can prevent the disease, but no specific antiviral drug is yet available for clinical therapy, and the death rate caused by JEV can reach as high as 60%. The C-terminus of non-struc...
Autores principales: | Fang, Jin’e, Li, Huan, Kong, Dexin, Cao, Shengbo, Peng, Guiqing, Zhou, Rui, Chen, Huanchun, Song, Yunfeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5041104/ https://www.ncbi.nlm.nih.gov/pubmed/27679979 http://dx.doi.org/10.1038/srep34550 |
Ejemplares similares
-
Identification of Three Antiviral Inhibitors against Japanese Encephalitis Virus from Library of Pharmacologically Active Compounds 1280
por: Fang, Jin'e, et al.
Publicado: (2013) -
Japanese Encephalitis Virus NS1′ Protein Interacts with Host CDK1 Protein to Regulate Antiviral Response
por: Li, Qiuyan, et al.
Publicado: (2021) -
Roles of TLR3 and RIG-I in Mediating the Inflammatory Response in Mouse Microglia following Japanese Encephalitis Virus Infection
por: Jiang, Rong, et al.
Publicado: (2014) -
Transcriptional regulation of miR-15b by c-Rel and CREB in Japanese encephalitis virus infection
por: Zhu, Bibo, et al.
Publicado: (2016) -
p21-Activated Kinase 4 Signaling Promotes Japanese Encephalitis Virus-Mediated Inflammation in Astrocytes
por: He, Wen, et al.
Publicado: (2017)